Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Plus Products Inc PLPRF

Consumer Cyclical Healthcare Advertising Agencies Drug Manufacturers - Specialty & Generic Cannabis
Plus Products Inc is a Canada based cannabis company with operations in the United States specializing in the development, manufacturing, marketing, and sale of cannabis-infused products in the state of California. Its products consist of cannabis-infused edibles, which the company sells to both the regulated medicinal and adult-use, or recreational, markets.


EXPM:PLPRF - Post by User

Plus Products Inc > Debenture proposal
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Comment by Leafs4Lifeon Feb 03, 2021 2:35pm
136 Views
Post# 32460502

RE:Debenture proposal

RE:Debenture proposal

I don't really understand it. Looks like they are offering a conversion for 6.5 million at 95 cents, which is less dilution than most were expecting. They're also extending the date for the remainder of the debenture and increasing the coupon from 8% to 12%. 

And there seems to be one more element to the deal that involves warrants at $1.10 per share, which I don't fully understand. 

Overall, it doesn't look like crippling dilution to me. I guess it's up to the debenture holders to decide. 

Method wrote: What do you all think?

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities